Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 4, 1998, Pages 381-386

  Hendel, H ^a   Henon N ^b   Lebuanec, H ^a   Lachgar, A ^a   Poncelet, H ^c   Caillat Zucman, S ^d   Winkler, C A ^e   Smith, M W ^e   Kenefic, L ^e   O'Brien, S ^f   Lu, W ^g   Andrieu, J M ^g   Zagury, D ^a   Schachter F ^a   Rappaport, J ^h   Zagury, J F ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b Lab de Genet du Vieilissement

^c Hôpital Pasteur

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g Hopital Laennec   (France)

^h DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

CCR2; CR5; Genetic polymorphisms; Progression to AIDS; SDF1

Indexed keywords

GENE PRODUCT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DELETION MUTANT; DISEASE COURSE; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 13144251182     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199812010-00009     Document Type: Article

References (22)

1. Hendel H, Cho Y-Y, Gauthier N, Rappaport J, Schachter F, Zagury J-F. Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results. Biomed Pharmacother 1996;50:480-7.
2. DeSouza MP, Harden VA. Chemokines and HIV-1 second receptors. Nat Med 1996;2:1293-1300.
3. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-5.
4. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996;273:1856-62.
5. Smith MW, Dean M, Carrington M, et al. Contrasting influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
6. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF1 chemokine gene variant. Science 1998; 279:389-93.
7. Biti R, French R, Young J, Bennetts B, Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 1997;3:252-3.
8. O'Brien TR, Winkler C, Dean M, et al. HIV-1 infection in a man homozygous for CCR5D32 [letter]. Lancet 1997;349:1219.
9. Theodorou I, Meyer L, Mageirowska M, Katlama C, Rouzioux C. HIV-1 infection in an individual homozygous for CCR5D32. Lancet 1997;349:1219-20.
10. Balotta C, Bagnarelli P, Violin M, et al. Homozygous D32 deletion of CCR5 chemokine receptor gene in an HIV-1 infected patient. AIDS 1997;11:67-71.
11. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
12. Michael NL, Louie LG, Rohrbaught AL, et al. The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-40.
13. Michael NL, Chang G, Louie LG, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997;3:1160-2.
14. Rappaport J, Cho Y-Y, Hendel H, Schwartz EJ, Schächter F, Zagury J-F. The 32 bp CCR5 gene deletion confers resistance to fast progression among HIV-1 infected heterozygous individuals. Lancet 1997;345:922-3.
15. Smith MW, Carrington M, Winkler C, et al. CCR2 chemokine receptor and AIDS progression. Nat Med 1997;3:1052-3.
16. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promotor mutation. Nat Med 1998;4:350-3.
17. Rizzardi GP, Morawetz RA, Vicenzi E, et al. CCR2 polymorphism and HIV disease. Nat Med 1998;4:252-53.
18. Lu W, Andrieu JM. An ultrasensitive test for the detection and quantitation of the plasma HIV RNA concentration. In: Retrovirus of human AIDS and related animal diseases. 11th Colloque des Cent Gardes. Amsterdam: Elsevier, 1997:315-23.
19. Ioannidis JPA, O'Brien TR, Rosenberg PS, Contopoulos-Ioannidis DG, Goedert JJ. Genetic effects on HIV disease progression. Nat Med 1998;4:536.
20. Moriuchi H, Moriuchi M, Fauci AS. Cloning and analysis of the promotor region of CCR5, a coreceptor for HIV-1 entry. J Immunol 1997;159:5441-9.
21. Guignard F, Combadiere C, Tiffany HL, Murphy PM. Gene organization and promotor function for CC chemokine receptor 5. J Immunol 1998;160:985-92.
22. Cohen OJ, Vaccarezza M, Lam GK, et al. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest 1997;100:1581-9.